VP, Chief Accounting Officer · Intellia Therapeutics, Inc. · Common Stock
Side
SELL
Value
$44K
Shares
2,641
Price
$16.78
Executed
Jul 1, 2026
Disclosed
Jul 6, 2026
Disclosure timeline5 days from execution to publication · legal deadline 2 business days
Jul 1 executedJul 6, 2026 disclosed
NTLA · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 3 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Dube Michael P filed this Form 4 reporting a open-market sale of NTLA on Jul 1, 2026. It became public on Jul 6, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
VP, Chief Accounting Officer
Dube Michael Pcik:0002019493
Issuer
Intellia Therapeutics, Inc.cik:0001652130
Revision history · 0
No field has changed since this record was first ingested.
